Cold agglutinin disease (CAD) was the likely trigger of repeated mini-strokes in an 84-year-old woman with already compromised blood…
Articles by Margarida Maia, PhD
Treatment with rituximab — commonly used off-label for cold agglutinin disease (CAD) — was reported to successfully resolve a…
Zydus Lifesciences’ desidustat eases the anemia and red blood cell destruction that mark autoimmune hemolytic anemia, or AIHA, a…
Parsaclisib, an experimental oral therapy from Incyte, safely and effectively increased levels of hemoglobin in about half of people…
Restarting Enjaymo (sutimlimab) after stopping it for up to four months was generally safe and brought blood markers of…
How childhood autoimmune hemolytic anemia (AIHA) — a group of rare conditions that includes cold agglutinin disease (CAD) — is…
The detection of cold agglutinins, the self-reactive antibodies that drive cold agglutinin disease (CAD), was crucial for the correct…
A woman in Costa Rica developed cold agglutinin disease (CAD) secondary to a diagnosis of systemic lupus erythematosus (SLE)…
A Japanese woman developed cold agglutination disease (CAD) following COVID-19 and a secondary bacterial infection in the lungs that…
Vermont Governor Phil Scott has signed into law a bill that improves access to the right medication at the right…